Related Experiment Videos
Preinduction cervical priming with PGE2 intracervical gel.
American Journal of Perinatology
|October 1, 1985
Summary
Prostaglandin E2 gel significantly improved cervical ripeness and reduced oxytocin needs for labor induction. This treatment showed no increase in adverse events or cesarean sections, offering a safe option for unfavorable cervices.
Area of Science:
- Obstetrics and Gynecology
- Reproductive Medicine
- Clinical Pharmacology
Background:
- Cervical ripening is crucial for successful labor induction.
- Unfavorable cervical conditions (Bishop score ≤ 4) pose challenges for induction.
- Prostaglandin E2 (PGE2) is a known agent for cervical ripening.
Purpose of the Study:
- To evaluate the safety and efficacy of intracervical PGE2 gel for cervical ripening.
- To assess the impact of PGE2 gel on labor induction parameters.
- To compare outcomes between PGE2 gel and a control group.
Main Methods:
- Prospective, randomized, controlled clinical trial.
- Administration of a single 0.5-mg dose of PGE2 gel intracervically 12 hours before oxytocin induction.
- 48 evaluable patients with unfavorable cervices (Bishop score ≤ 4) were enrolled.
Main Results:
- PGE2 gel significantly improved mean Bishop scores (3.14 vs. 0.70, P < .00005).
- 64% of PGE2 group had contractions vs. 9% in control (P = .0001).
- Reduced oxytocin infusion duration (13.1 vs. 19.0 hours, P < .05) with no increased C-section rates.
Conclusions:
- Intracervical PGE2 gel is effective in improving cervical ripeness.
- PGE2 gel facilitates labor induction and reduces oxytocin requirements.
- The treatment is safe, with no reported uterine hypertonus or significant side effects.